相似文献
1
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.
J Clin Microbiol. 2007 Feb;45(2):614-5. doi: 10.1128/JCM.01351-06. Epub 2006 Dec 6.
2
Identification and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran, Iran.
New Microbiol. 2010 Jul;33(3):243-8.
3
Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica.
J Med Microbiol. 2015 Jan;64(Pt 1):37-43. doi: 10.1099/jmm.0.081802-0. Epub 2014 Oct 29.
4
Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
BMC Infect Dis. 2013 Oct 29;13:505. doi: 10.1186/1471-2334-13-505.
5
Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
Microb Drug Resist. 2018 Oct;24(8):1108-1116. doi: 10.1089/mdr.2017.0258. Epub 2018 Feb 13.
6
Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Burns. 2014 Dec;40(8):1556-61. doi: 10.1016/j.burns.2014.02.010. Epub 2014 Apr 22.
7
SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Diagn Microbiol Infect Dis. 2018 Mar;90(3):221-227. doi: 10.1016/j.diagmicrobio.2017.11.003. Epub 2017 Nov 10.
8
Prevalence of blaIMP, and blaVIM gene carriage in metallo-β-lactamase-producing burn isolates of Pseudomonas aeruginosa in Tehran.
Turk J Med Sci. 2014;44(3):511-4. doi: 10.3906/sag-1302-67.
9
Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115174. doi: 10.1016/j.diagmicrobio.2020.115174. Epub 2020 Aug 12.
10
Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla, bla, bla, bla and bla.
Int J Antimicrob Agents. 2020 Jul;56(1):106026. doi: 10.1016/j.ijantimicag.2020.106026. Epub 2020 May 22.
引用本文的文献
1
Update on bacterial pathogens: virulence and resistance.
Enferm Infecc Microbiol Clin. 2008 Apr;26:3-21. doi: 10.1016/S0213-005X(08)76378-X. Epub 2009 May 13.
2
Difficult-to-treat (DTR) harboring Verona-Integron metallo-β-lactamase (): infection management and molecular analysis.
Antimicrob Agents Chemother. 2024 May 2;68(5):e0147423. doi: 10.1128/aac.01474-23. Epub 2024 Apr 11.
3
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.
Expert Rev Anti Infect Ther. 2018 Feb;16(2):89-110. doi: 10.1080/14787210.2018.1425139. Epub 2018 Jan 16.
4
First Report of a Verona Integron-Encoded Metallo-β-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United States.
J Pediatric Infect Dis Soc. 2016 Sep;5(3):e24-7. doi: 10.1093/jpids/piw025. Epub 2016 May 4.
5
Dissemination of carbapenemases producing Gram negative bacteria in the Middle East.
Iran J Microbiol. 2015 Oct;7(5):226-46.
6
Antibiotic-resistant gram-negative bacterial infections in patients with cancer.
Clin Infect Dis. 2014 Nov 15;59 Suppl 5(Suppl 5):S335-9. doi: 10.1093/cid/ciu612.
7
Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio.
Antimicrob Agents Chemother. 2014 Oct;58(10):5929-35. doi: 10.1128/AAC.02372-14. Epub 2014 Jul 28.
8
Evaluation of Zataria MultiFlora Boiss and Carum copticum antibacterial activity on IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Ann Burns Fire Disasters. 2013 Dec 31;26(4):193-8.
9
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
J Med Chem. 2010 Apr 22;53(8):3013-27. doi: 10.1021/jm9012938.
10
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2010 Mar;54(3):1160-4. doi: 10.1128/AAC.01446-09. Epub 2010 Jan 19.
本文引用的文献
1
Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
Antimicrob Agents Chemother. 2006 May;50(5):1633-41. doi: 10.1128/AAC.50.5.1633-1641.2006.
2
The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
Clin Microbiol Infect. 2005 Nov;11 Suppl 6:2-9. doi: 10.1111/j.1469-0691.2005.01264.x.
3
Emerging epidemic of metallo-beta-lactamase-mediated resistances.
Diagn Microbiol Infect Dis. 2005 Feb;51(2):77-84. doi: 10.1016/j.diagmicrobio.2004.07.003.
4
The new beta-lactamases.
N Engl J Med. 2005 Jan 27;352(4):380-91. doi: 10.1056/NEJMra041359.
5
Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals.
Antimicrob Agents Chemother. 2005 Jan;49(1):104-10. doi: 10.1128/AAC.49.1.104-110.2005.
6
Prevalence and characterization of metallo-beta-lactamases in clinical isolates of pseudomonas aeruginosa.
Diagn Microbiol Infect Dis. 2004 Feb;48(2):131-5. doi: 10.1016/j.diagmicrobio.2003.09.005.
7
blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States.
Antimicrob Agents Chemother. 2004 Jan;48(1):329-32. doi: 10.1128/AAC.48.1.329-332.2004.
8
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2003 Sep;47(9):2859-63. doi: 10.1128/AAC.47.9.2859-2863.2003.
9
bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.
Antimicrob Agents Chemother. 2002 Apr;46(4):1053-8. doi: 10.1128/AAC.46.4.1053-1058.2002.
10
Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds.
J Clin Microbiol. 2000 Jan;38(1):40-3. doi: 10.1128/JCM.38.1.40-43.2000.
Zotero 插件